Navigation Links
$74 Million Settlement Reached Regarding Pricing of Cipro
Date:9/3/2013

SAN DIEGO, Sept. 3, 2013 /PRNewswire-USNewswire/ -- The following is being released by the law firms of Lieff Cabraser Heimann & Bernstein, LLP, Zwerling, Schachter & Zwerling, LLP, the Joseph Saveri Law Firm, Inc., and Krause, Kalfayan Benink & Slavens, LLP.

A partial settlement has been reached in a class action lawsuit involving the prescription antibiotic Cipro.  The lawsuit claims Bayer Corporation, Barr Laboratories, Inc., Hoechst Marion Roussel, Inc., Watson Pharmaceuticals, Inc., and The Rugby Group, Inc. violated antitrust and consumer protection laws by agreeing not to compete with each other, and by keeping lower-cost generic versions of Cipro off the market.  The manufacturers deny these claims.

This settlement is with Bayer Corporation only; the case against the other manufacturers continues.

Neither the case nor the settlement is about the safety or effectiveness of Cipro.

Bayer has paid $74 million into a settlement fund that will compensate consumers and third-party payors (Class Members) who paid or reimbursed for Cipro in California between January 8, 1997 and October 31, 2004.  Cipro purchasers not eligible for settlement payments include: (1) anyone who received Cipro through the MediCal Prescription Drug Program, (2) anyone who purchased Cipro to resell it, (3) government entities, (4) the manufacturers and related entities being sued, and (5) all purchasers of Cipro who paid a flat co-payment and who would have paid the same co-payment for a generic version under their health insurance policy.

Individual payments will be based on the total number of valid claims filed and how much the Class Member paid or reimbursed for Cipro.  Attorneys' fees not to exceed one-third of the fund, litigation costs, and other fees and expenses will be deducted prior to distribution.  Full details about the settlement can be found in the Settlement Agreement, which is available at www.CiproSettlement.com.  

Class Members must submit a claim form by March 31, 2014 in order to get a payment.  The claim form and instructions on how to submit it are available at www.CiproSettlement.com or by calling 1-866-404-0135. 

Class Members may comment on or object to the settlement by October 16, 2013.  Details on how to comment or object are available at www.CiproSettlement.com.

The Court will hold a hearing on November 15, 2013 to consider whether to finally approve the settlement and whether to approve Class Counsel's application for attorneys' fees, reimbursement of expenses, and service awards for Class Representatives.

For more information about the settlement or to obtain a claim form, visit: www.CiproSettlement.com or call 1-866-404-0135.


'/>"/>
SOURCE Lieff Cabraser Heimann & Bernstein, LLP, Zwerling, Schachter & Zwerling, LLP, the Joseph Saveri Law Firm, Inc., and Krause, Kalfayan Benink & Slavens, LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
4. Arthrosurface Hits a $100 Million Milestone
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
7. Independa Closes Convertible Note Funding at $2.35 Million
8. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
(Date:6/8/2017)... LOS ANGELES , June 8, 2017   Responding ... prescription drug oversight and the death of singer Chris ... Commission on Human Rights International offers a free online ...  to better educate consumers and families about psychotropic drug risks. ... Heath Ledger , who died from an accidental overdose, has ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... 28, 2017 , ... Quorum Health announced that Robert A. Vento has been ... John Maher was promoted to COO of QHR. , A national search ... president and CEO in December 2016. , “I’m pleased to announce ...
(Date:6/28/2017)... ... ... Drs. Steven Crandall, Karen Johnson and Kathy Lopez are now accepting new ... PA, without a referral. The doctors address jaw pain and other symptoms ... facial muscles that support it. , Jaw pain can be debilitating, and when ...
(Date:6/28/2017)... ... ... remote control has seen the never-ending twists on the house flipping show genre. The shows ... time. But what about the buyers of the flipper's flip. , Here is ... An email recently sent to Gary Case said, “Just closed on a home on ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton ... for mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market ... on the University of Pennsylvania campus, followed by the two-day convention, which will ...
(Date:6/28/2017)... Vancouver, British Columbia (PRWEB) , ... June 28, ... ... (OTCQB: CNZCF) (FSE: ZEON) is pleased to announce that a two year study ... using the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. ...
Breaking Medicine News(10 mins):